Cancel anytime
Sharecare Inc (SHCR)SHCR
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: SHCR (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Profit: -23.66% | Upturn Advisory Performance 2 | Avg. Invested days: 35 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Profit: -23.66% | Avg. Invested days: 35 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 521.16M USD |
Price to earnings Ratio - | 1Y Target Price 1.43 |
Dividends yield (FY) - | Basic EPS (TTM) -0.38 |
Volume (30-day avg) 1712647 | Beta 0.51 |
52 Weeks Range 0.48 - 1.42 | Updated Date 09/18/2024 |
Company Size Small-Cap Stock | Market Capitalization 521.16M USD | Price to earnings Ratio - | 1Y Target Price 1.43 |
Dividends yield (FY) - | Basic EPS (TTM) -0.38 | Volume (30-day avg) 1712647 | Beta 0.51 |
52 Weeks Range 0.48 - 1.42 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -33.64% | Operating Margin (TTM) -42.06% |
Management Effectiveness
Return on Assets (TTM) -14.19% | Return on Equity (TTM) -28.24% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE - | Forward PE 68.49 |
Enterprise Value 435708921 | Price to Sales(TTM) 1.29 |
Enterprise Value to Revenue 1.08 | Enterprise Value to EBITDA -16.93 |
Shares Outstanding 370931008 | Shares Floating 297219318 |
Percent Insiders 10.32 | Percent Institutions 40.09 |
Trailing PE - | Forward PE 68.49 | Enterprise Value 435708921 | Price to Sales(TTM) 1.29 |
Enterprise Value to Revenue 1.08 | Enterprise Value to EBITDA -16.93 | Shares Outstanding 370931008 | Shares Floating 297219318 |
Percent Insiders 10.32 | Percent Institutions 40.09 |
Analyst Ratings
Rating 3 | Target Price 3.19 | Buy - |
Strong Buy - | Hold 3 | Sell - |
Strong Sell - |
Rating 3 | Target Price 3.19 | Buy - | Strong Buy - |
Hold 3 | Sell - | Strong Sell - |
AI Summarization
Sharecare Inc. Stock Overview:
Company Profile:
History: Sharecare was founded in 2011 through a joint venture between WebMD and Discovery Communications. Its goal was to bring personalized health and wellness content to consumers. In 2021, Sharecare went public via a SPAC merger.
Core Business Areas: Sharecare provides a digital platform for individuals to manage their health and wellness. This platform offers a variety of tools and resources, including:
- Health Assessment: Tools to assess health risks and set goals.
- Content Library: Educational content on various health topics.
- Community: Forums and groups for peer support and information sharing.
- Care Navigation: Tools to find and connect with healthcare providers.
- Well-being Programs: Programs to promote healthy habits and behaviors.
Leadership: Sharecare's leadership team includes:
- CEO Jeff Arnold: Former CEO of WebMD.
- Executive Chairman Dr. Mehmet Oz: Former host of “The Dr. Oz Show”.
- President and COO Sachin Jain: Former Chief Product Officer at Optum (UnitedHealth Group).
Top Products and Market Share:
- Sharecare App: Personalized health platform with tools for goal setting, tracking progress, and connecting with providers.
- RealAge Test: An online assessment that estimates a user's biological age based on lifestyle and health factors.
- HealthRisk: AI-powered tool that analyzes EMR data to identify potential health risks for individuals.
Market Share: Sharecare operates in a highly competitive market with players like Livongo, Omada Health, and Welltok. Sharecare's exact market share is not publicly available, but it is estimated to be a small player in the overall digital health market.
Total Addressable Market: The global digital health market is estimated to be worth $350 billion in 2023 and is projected to grow to $982 billion by 2028.
Financial Performance:
- Revenue: Sharecare's revenue in 2022 was $664 million, an increase of 74% year-over-year.
- Net Income: The company reported a net loss of $90 million in 2022, compared to a net loss of $151 million in 2021.
- Profit Margins: Sharecare is not yet profitable, with a gross margin of 13% and an operating margin of -17% in 2022.
- Earnings Per Share (EPS): The company reported an EPS of -$0.84 in 2022.
Dividends and Shareholder Returns:
- Dividend History: Sharecare does not currently pay dividends.
- Shareholder Returns: Since its IPO in 2021, Sharecare's stock price has declined by over 90%.
Growth Trajectory:
- Historical Growth: Sharecare has experienced strong revenue growth in recent years, but it is still operating at a loss.
- Future Growth Projections: The company expects to continue growing revenue at a rapid pace in the years to come. It is also aiming to achieve profitability, but it has not yet provided a specific timeline.
- Recent Growth Initiatives: Sharecare has been expanding its partnerships with health systems and employers. It has also been investing in new product development, such as its AI-powered HealthRisk tool.
Market Dynamics:
- Industry Trends: The digital health market is growing rapidly as consumers become more engaged with their health and wellness.
- Demand-Supply: The demand for digital health tools and services is expected to continue to grow in the years to come. However, the market is becoming increasingly crowded, with many different players competing for market share.
- Technological Advancements: AI and machine learning are playing an increasingly important role in digital health. These technologies are being used to develop new tools and services that can personalize the healthcare experience and improve outcomes.
Sharecare's Position: Sharecare is well-positioned to benefit from these trends due to its strong brand recognition, user-friendly platform, and partnerships with large healthcare organizations. However, the company faces stiff competition and needs to demonstrate its ability to achieve profitability.
Competitors:
- Livongo (LVGO): A digital health company that focuses on chronic conditions like diabetes and hypertension.
- Omada Health (OMAD): A digital health company that provides virtual coaching programs for chronic conditions.
- Welltok (WELL): A digital health company that provides personalized engagement platforms for health plans and employers.
Key Challenges and Opportunities:
- Challenge: Competition is fierce in the digital health space, putting pressure on margins and requiring sustained innovation.
- Opportunity: The growing market for digital health presents a significant opportunity for Sharecare to expand its user base and generate revenue.
Recent Acquisitions:
- MyNetDiary (2020): A calorie-counting and meal-planning app. This acquisition aimed to expand Sharecare's digital health ecosystem and cater to users actively managing their eating habits.
- LifeClinic (2021): A virtual care platform focused on digestive health. This purchase aimed to diversify Sharecare's offerings and provide specialized care options.
- Vaunn Medical (2021): A remote patient monitoring company. This acquisition added capabilities to remotely monitor a wider range of health conditions, enhancing Sharecare's chronic disease management portfolio.
AI-Based Fundamental Rating:
- Rating: 6/10
- Justification: Sharecare shows promise through strong brand recognition, partnerships, and user-friendly platform. However, its lack of profitability, intense competition, and declining share price raise concerns.
Sources:
- Sharecare Investor Relations: https://investors.sharecare.com/
- SEC Edgar Filings: https://www.sec.gov/edgar/search/
- Business of Apps: https://businessofapps.com/data/sharecare-statistics/
Disclaimer: This information is for informational purposes only and should not be considered investment advice. Investing in stocks involves risk, and you could lose money.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Sharecare Inc
Exchange | NASDAQ | Headquaters | Atlanta, GA, United States |
IPO Launch date | 2020-11-23 | CEO & Director | Mr. Brent Davis Layton |
Sector | Healthcare | Website | https://www.sharecare.com |
Industry | Health Information Services | Full time employees | 3352 |
Headquaters | Atlanta, GA, United States | ||
CEO & Director | Mr. Brent Davis Layton | ||
Website | https://www.sharecare.com | ||
Website | https://www.sharecare.com | ||
Full time employees | 3352 |
Sharecare, Inc. operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to improve their health and well-being. It also operates RealAge, a platform for health assessment to assess behaviors and existing conditions of its members and provide metric for their physical health. In addition, the company provides secure, automated release of information, audit, and business consulting services to streamline the medical records process for medical facilities. It sells its solutions through direct sales organization and partner relationships. Sharecare, Inc. was founded in 2009 and is headquartered in Atlanta, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.